1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pakistan Pharmaceuticals and Healthcare Report Q2 2016

Pakistan Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 104 pages

Includes 3 FREE quarterly updates

BMI View: A challenging business environment will perpetuate the fragmented and underdevelopedpharmaceutical market in Pakistan. Patent protection in the country is poor, dissuading local firms frominvesting into research and multinational drugmakers from launching new innovative treatments in thecountry. Moreover, the country has a tough pricing environment and an equally challenging distributionsystem which will continue to hinder the growth of pharmaceutical firms. Consequently, Pakistan-baseddrugmakers will focus on overseas markets where higher margins present stronger opportunities forgrowth.

Headline Expenditure Projections

- Pharmaceuticals: PKR252bn (USD2.4bn) in 2015 to PRK273bn (USD2.5bn) 2016; +8.2%in localcurrency terms and +5.1% in US dollar terms.

- Healthcare: PKR725bn (USD7bn) in 2015 to PKR804bn (USD7.6bn) in 2016; +11% in local currencyterms and +7.6% in US dollar terms.

Table Of Contents

Pakistan Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Pakistan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Pakistan 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020) 16
Table: Government Healt Expenditure Trends, Historical Data And Forecasts (Pakistan 2010-2018) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Pakistan 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Pakistan 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Pakistan 2014-2020) 30
Industry Risk/Reward Index 31
Asia Pacific Risk/Reward Index 31
Pakistan Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Regulatory Developments 42
Intellectual Property Issues 42
Pricing Regime 43
Reimbursement Regime 45
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Pakistan 2010-2015) 50
Table: Healthcare Personnel (Pakistan 2010-2015) 50
Table: Healthcare Activity (Pakistan 2010-2015) 51
Research and Development 51
Clinical Trials 52
Epidemiology 53
Table: Diabetic Patients' Education Level and Compliance Levels 55
Table: Estimated Number Of New Cases Of Cancer In Pakistan 56
Table: Frequency Of Information Provided To Patients As A Percentage Of Total Cases 56
Competitive Landscape 58
Research-Based Industry 58
Table: Multinational Market Activity 58
Generic Drugmakers 59
Table: PPMA As Of 2015 60
Pharmaceutical Distribution 63
Company Profile 65
Abbott Laboratories 65
Efroze Chemical Industries 68
Ferozsons Laboratories 71
Getz Pharma 74
GlaxoSmithKline (GSK) 77
Hilton Pharma 81
Novartis 83
Pfizer 85
Sanofi-Aventis 88
Searle Pakistan Limited 91
Demographic Forecast 93
Table: Population Headline Indicators (Pakistan 1990-2025) 94
Table: Key Population Ratios (Pakistan 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Pakistan 1990-2025) 95
Table: Population By Age Group (Pakistan 1990-2025) 95
Table: Population By Age Group % (Pakistan 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.